Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Hepatitis C

  Free Subscription

Articles published in Virology

Retrieve available abstracts of 24 articles:
HTML format

Single Articles

    February 2021
  1. KANG X, Chen X, He Y, Guo D, et al
    Corrigendum to "DDB1 is a cellular substrate of NS3/4A protease and required for hepatitis C virus replication" [Virology 435 (2013) 385-394].
    Virology. 2021 Feb 8. pii: S0042-6822(21)00021.

    June 2020
  2. LAFONTAINE E, Miller CM, Permaul N, Martin ET, et al
    Ribosomal protein RACK1 enhances translation of poliovirus and other viral IRESs.
    Virology. 2020;545:53-62.
    PubMed     Abstract available

    October 2019
  3. FORBERG K, Rodgers MA, Dawson GJ, Sauleda S, et al
    Human pegivirus 2 exhibits minimal geographic and temporal genetic diversity.
    Virology. 2019;539:69-79.
    PubMed     Abstract available

    September 2019
  4. MEJER N, Galli A, Ramirez S, Fahnoe U, et al
    Ribavirin inhibition of cell-culture infectious hepatitis C genotype 1-3 viruses is strain-dependent.
    Virology. 2019;540:132-140.
    PubMed     Abstract available

    July 2019
  5. ZHANG Y, Zhao X, Zou J, Yuan Z, et al
    Dual role of the amphipathic helix of hepatitis C virus NS5A in the viral polyprotein cleavage and replicase assembly.
    Virology. 2019;535:283-296.
    PubMed     Abstract available

  6. LU G, Ou J, Sun Y, Wu L, et al
    Natural recombination of equine hepacivirus subtype 1 within the NS5A and NS5B genes.
    Virology. 2019;533:93-98.
    PubMed     Abstract available

    February 2019
  7. JALAL PJ, King BJ, Saeed A, Adedeji Y, et al
    Elevated serum activity of MBL and ficolin-2 as biomarkers for progression to hepatocellular carcinoma in chronic HCV infection.
    Virology. 2019;530:99-106.
    PubMed     Abstract available

    January 2019
  8. SUZUKI R, Matsuda M, Shimoike T, Watashi K, et al
    Activation of protein kinase R by hepatitis C virus RNA-dependent RNA polymerase.
    Virology. 2019;529:226-233.
    PubMed     Abstract available

    August 2018
  9. ZHANG H, Qiao L, Luo G
    Characterization of apolipoprotein C1 in hepatitis C virus infection and morphogenesis.
    Virology. 2018;524:1-9.
    PubMed     Abstract available

  10. GALLEGO I, Gregori J, Soria ME, Garcia-Crespo C, et al
    Resistance of high fitness hepatitis C virus to lethal mutagenesis.
    Virology. 2018;523:100-109.
    PubMed     Abstract available

    July 2018
  11. HUMES D, Ramirez S, Jensen TB, Li YP, et al
    Recombinant hepatitis C virus genotype 5a infectious cell culture systems expressing minimal JFH1 NS5B sequences permit polymerase inhibitor studies.
    Virology. 2018;522:177-192.
    PubMed     Abstract available

    May 2018
  12. WU Q, Li Z, Liu Q
    An important role of SREBP-1 in HBV and HCV co-replication inhibition by PTEN.
    Virology. 2018;520:94-102.
    PubMed     Abstract available

    April 2018
  13. KRAPCHEV VB, Rychlowska M, Chmielewska A, Zimmer K, et al
    Recombinant Flag-tagged E1E2 glycoproteins from three hepatitis C virus genotypes are biologically functional and elicit cross-reactive neutralizing antibodies in mice.
    Virology. 2018;519:33-41.
    PubMed     Abstract available

    March 2018
  14. LI J, Feng S, Liu X, Guo M, et al
    Identification of nucleotides in the 5'UTR and amino acids substitutions that are essential for the infectivity of 5'UTR-NS5A recombinant of hepatitis C virus genotype 1b (strain Con1).
    Virology. 2018;518:253-263.
    PubMed     Abstract available

    February 2018
  15. HUANG K, Chen J, Xu R, Jiang X, et al
    Molecular evolution of hepatitis C virus in China: A nationwide study.
    Virology. 2018;516:210-218.
    PubMed     Abstract available

    December 2017
  16. MANICKAM C, Martinot AJ, Jones RA, Varner V, et al
    Hepatic immunopathology during occult hepacivirus re-infection.
    Virology. 2017;512:48-55.
    PubMed     Abstract available

    November 2017
  17. CAMUS G, Xu S, Han B, Lu J, et al
    Establishment of robust HCV genotype 4d, 5a, and 6a replicon systems.
    Virology. 2017;514:134-141.
    PubMed     Abstract available

  18. MESALAM AA, Desombere I, Farhoudi A, Van Houtte F, et al
    Development and characterization of a human monoclonal antibody targeting the N-terminal region of hepatitis C virus envelope glycoprotein E1.
    Virology. 2017;514:30-41.
    PubMed     Abstract available

    August 2017
  19. WU Q, Li Z, Liu Q
    Treatment with PTEN-Long protein inhibits hepatitis C virus replication.
    Virology. 2017;511:1-8.
    PubMed     Abstract available

    April 2017
  20. BIEGEL JM, Henderson E, Cox EM, Bonenfant G, et al
    Cellular DEAD-box RNA helicase DDX6 modulates interaction of miR-122 with the 5' untranslated region of hepatitis C virus RNA.
    Virology. 2017;507:231-241.
    PubMed     Abstract available

  21. EYRE NS, Aloia AL, Joyce MA, Chulanetra M, et al
    Sensitive luminescent reporter viruses reveal appreciable release of hepatitis C virus NS5A protein into the extracellular environment.
    Virology. 2017;507:20-31.
    PubMed     Abstract available

  22. KHERA L, Paul C, Kaul R
    Hepatitis C Virus E1 protein promotes cell migration and invasion by modulating cellular metastasis suppressor Nm23-H1.
    Virology. 2017;506:110-120.
    PubMed     Abstract available

    October 2016
  23. MISHRA P, Dixit U, Pandey AK, Upadhyay A, et al
    Modulation of HCV replication and translation by ErbB3 binding protein1 isoforms.
    Virology. 2016;500:35-49.
    PubMed     Abstract available

    September 2016
  24. MAC DONALD-OTTEVANGER MS, Vreden S, van der Helm JJ, van de Laar T, et al
    Prevalence, determinants and genetic diversity of hepatitis C virus in the multi-ethnic population living in Suriname.
    Virology. 2016;499:114-120.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis C is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.